Resilience Through Reinvention: How Pharma is Navigating Uncertainty During Turbulent Times

pharma; resilience; reinvention; supply chain; manufacturing uncertainty; regulatory environment; global market adaptation; funding; investment; clinical trials; drug pricing policy; APIs; strategic reserves

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration